“ASTER votes no on this bill. Today, every citizen is protected by a legal price ceiling on all prescription medication — a universal guarantee. This proposal narrows that protection to public purchases only, leaving anyone who buys medication outside the public system exposed to whatever price the pharmaceutical industry sets. State negotiation for public procurement is not a bad tool on its own, but it cannot replace a universal safeguard; it simply shifts risk onto the citizens least able to absorb it. The claim that price ceilings stifle innovation asks patients to subsidize corporate margins with their own health. ASTER will support state negotiation as a complement to price protection, not as a replacement for it. We remain open to a revised proposal that expands coverage rather than narrows it.”
State Prescription Drug Negotiations Act of 2024
Rationale
Help our stagnant economy, liberalize the market somewhat so the law passes in the Nordting, while still looking after our citizens with a negotiation for all medicine prices so pharmaceuticals do not go overboard with the prices.
Proposed Changes
| Law | Previous | Proposed | ||
|---|---|---|---|---|
| 1 | Prescription Drug Pricing |
Statutory price caps on all medicines
|
State negotiates prices for public purchasing
|
1
Prescription Drug PricingProposer
Party
Libertarian Alliance
The party of bold growth and unshackled freedom where ambition meets opportunity and every dream is a spark for the next fire.
Core pillars
Malin Larsson
Minister of National Defense · Age 55
Once a rising star in the business world turned political operator, Malin Larsson trades ideology for results, blending sharp analysis with an uncanny ability to rally allies and outmaneuver opponents on her way to the top.
Timeline
-
Draft13 March 2024
-
Vote Open12 May 2024
-
Vote Closed11 July 2024
-
Did Not Become Law11 July 2024
Vote tally
Live tally across each chamber. Weighted by seats held.
Nordting
FailedFor: 13 / 35 seats (37.1%)
Against: 20 · Abstained: 0 · Not voted: 2
| Party | Seats | Vote | Reason |
|---|---|---|---|
| A Better Fjordheim | 6 | Yes | ABF supports replacing blanket price controls with targeted state negotiation, allowing greater market freedom while ensuring taxpayers receive fair prices on publicly purchased medicines. |
| ASTER | 20 | No | ASTER votes no on this bill. Today, every citizen is protected by a legal price ceiling on all prescription medication — a universal guarantee. This proposal narrows that protection to public purchases only, leaving anyone who buys medication outside the public system exposed to whatever price the pharmaceutical industry sets. State negotiation for public procurement is not a bad tool on its own, but it cannot replace a universal safeguard; it simply shifts risk onto the citizens least able to absorb it. The claim that price ceilings stifle innovation asks patients to subsidize corporate margins with their own health. ASTER will support state negotiation as a complement to price protection, not as a replacement for it. We remain open to a revised proposal that expands coverage rather than narrows it. |
| Democratic Liberal Platform | 5 | Yes | Even though we aim for affordable medicine and care for those who need it, too stringent price caps hinders innovation. It does not incentivize companies to come up with new and better ways to treat patients. Allowing some profit-making alleviates this issue. It is much better to directly help low-income households being able to afford the care they need, instead of targeting the companies that provide it. |
| Libertarian Alliance Proposer | 2 | Yes | No reason given |
Voting record
Every vote must state a public reason. Most recent first.
“Even though we aim for affordable medicine and care for those who need it, too stringent price caps hinders innovation. It does not incentivize companies to come up with new and better ways to treat patients. Allowing some profit-making alleviates this issue. It is much better to directly help low-income households being able to afford the care they need, instead of targeting the companies that provide it.”
“ABF supports replacing blanket price controls with targeted state negotiation, allowing greater market freedom while ensuring taxpayers receive fair prices on publicly purchased medicines.”